Censo Bio is a specialist CNS discovery services company using human iPSC to support neurodegenerative and neuro-inflammation focused discovery projects.
Censo provides access to a diverse range of existing human iPSC lines, and ethically sources relevant human tissue, both healthy and with disease specific mutations, with which to custom generate new iPSC lines from large cohorts of individuals.
We can gene edit these lines to knock in, knock out or correct target genes of interest, and have developed reproducible differentiation protocols for a number of lineages, including microglia, astrocytes, cortical, and sensory neurons.
Using these cells for neurodegenerative and neuro-inflammatory disease discovery, we offer customisable phenotypic assays to deliver new insights and functional disease related understanding of our clients compounds,
Our technology also enables the study of genotype-phenotype relationships in large populations, providing an understanding of patient population therapeutic response variability.